CA2426564A1 - Pyranoside derivatives - Google Patents

Pyranoside derivatives Download PDF

Info

Publication number
CA2426564A1
CA2426564A1 CA002426564A CA2426564A CA2426564A1 CA 2426564 A1 CA2426564 A1 CA 2426564A1 CA 002426564 A CA002426564 A CA 002426564A CA 2426564 A CA2426564 A CA 2426564A CA 2426564 A1 CA2426564 A1 CA 2426564A1
Authority
CA
Canada
Prior art keywords
compounds
general formula
formula
preparing
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002426564A
Other languages
English (en)
French (fr)
Inventor
Ralf Anderskewitz
Kurt Schromm
Franz Birke
Hans Michael Jennewein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2426564A1 publication Critical patent/CA2426564A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002426564A 2000-10-24 2001-10-19 Pyranoside derivatives Abandoned CA2426564A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10052658.6 2000-10-24
DE10052658A DE10052658A1 (de) 2000-10-24 2000-10-24 Neue Pyranosidderivate
PCT/EP2001/012128 WO2002034761A1 (de) 2000-10-24 2001-10-19 Pyranosidderivate

Publications (1)

Publication Number Publication Date
CA2426564A1 true CA2426564A1 (en) 2002-05-02

Family

ID=7660865

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002426564A Abandoned CA2426564A1 (en) 2000-10-24 2001-10-19 Pyranoside derivatives

Country Status (7)

Country Link
EP (1) EP1332151A1 (es)
JP (1) JP2004513100A (es)
AU (1) AU2002215965A1 (es)
CA (1) CA2426564A1 (es)
DE (1) DE10052658A1 (es)
MX (1) MXPA03003466A (es)
WO (1) WO2002034761A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997491B1 (en) * 2004-07-14 2010-09-22 Inflammation Research Center Company Ltd. Method for inhibiting tumor metastasis
AU2018266393A1 (en) * 2017-05-12 2019-12-19 Riken Class A GPCR-binding compound modifier

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19637123A1 (de) * 1996-09-12 1998-03-19 Boehringer Ingelheim Kg Neue Pyranosidderivate

Also Published As

Publication number Publication date
DE10052658A1 (de) 2002-05-02
WO2002034761A1 (de) 2002-05-02
EP1332151A1 (de) 2003-08-06
MXPA03003466A (es) 2004-09-10
JP2004513100A (ja) 2004-04-30
AU2002215965A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
CN101119993A (zh) 作为选择性雄激素受体调节剂的氨基苯基衍生物
JP2004515452A (ja) アンチチュウブリンアセンブ称する細胞成長抑制剤
JPS58162554A (ja) ２−（ｐ−イソブチルフエニル）プロピオン酸誘導体、その製造法およびそれを有効成分とする医薬
US6197824B1 (en) Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
HU184959B (en) Process for producing new amino-ethanel derivatives
WO2011091710A1 (zh) 苯基c-葡萄糖苷衍生物、其制备方法和用途
WO2010040286A1 (zh) 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
US5686496A (en) Chemical compound, the preparation thereof and its use in pharmaceutical compositions
CS208660B2 (en) Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives
CA2263846C (en) Novel pyranoside derivatives
US6653348B2 (en) 6-methoxy-2-naphthylacetic acid prodrugs
EP0162975B1 (en) P-alkyl or cycloalkyl phenoxy alkanols and alkanol esters and use for the treatment of allergic conditions
CA2426564A1 (en) Pyranoside derivatives
US6291531B1 (en) LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
US6528491B2 (en) Pyranoside derivatives
WO2021218833A1 (zh) 一种m受体拮抗剂的晶体、制备方法及其应用
US6197753B1 (en) Pyranoside derivatives
JPS62120398A (ja) エストロゲンの置換安息香酸エステルプロ薬物
CA2425368C (en) New sulphoxybenzamides
MXPA02004355A (es) Composiciones de profarmacos de acido 6-metoxi-2-naftilacetico para tratar la inflamacion.
US6133479A (en) Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
JP2000511916A (ja) ポリオールスクシネートおよびその医薬製剤
EP0147174B1 (en) Dihydroxybenzaldehyde derivatives as anti-inflammatory agents
JP4428900B2 (ja) 新規ｌｔｂ４拮抗薬、その調製方法及び医薬組成物としてその使用
JPH0341458B2 (es)

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead